AI assistant
ULTRALIFE CORP — Director's Dealing 2013
Jun 6, 2013
34105_dirs_2013-06-06_13043957-3274-4e71-b14d-bc87cdfe2323.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2013-06-04
Reporting Person: POPIELEC MICHAEL D (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-06-04 | Restricted Stock Units | $ | A | 120000 | Acquired | 2020-12-30 | Common Stock (120000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock; $.10 par value | 185000 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
F2: This award of Conditional Restricted Stock Units was granted on January 29, 2013 subject to shareholder approval, which occurred on June 4, 2013.
F3: 30,000 shares will vest on the later of January 1, 2014 or the date when the common stock first reaches a closing price of $4.00 per share for 15 trading days in a 30 trading-day period; 30,000 shares will vest on the later of January 1, 2014 or the date when the common stock first reaches a closing price of $5.00 per share for 15 trading days in a 30 trading-day period; 30,000 shares will vest on the later of January 1, 2015 or the date when the common stock first reaches a closing price of $4.00 per share for 15 trading days in a 30 trading-day period; and 30,000 shares will vest on the later of January 1, 2015 or the date when the common stock first reaches a closing price of $5.00 per share for 15 trading days in a 30 trading-day period.